ClinConnect ClinConnect Logo
Search / Trial NCT06676098

The Optimal Injection Site for a 3D Guided Inferior Alveolar Nerve Block Device (IANBD)

Launched by BOSTON UNIVERSITY · Nov 4, 2024

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

Inferior Alveolar Nerve Block (Ianb) Inferior Alveolar Nerve Block Device (Ianbd) 3 D Guided Ianbd Cone Beam Computed Tomography (Cbct)

ClinConnect Summary

This clinical trial, titled "The Optimal Injection Site for a 3D Guided Inferior Alveolar Nerve Block Device (IANBD)," is exploring a new way to provide anesthesia for dental procedures involving the lower jaw. Traditional methods of numbing this area can be tricky and may not always work well, leading to discomfort for patients. This trial will test a new device that uses 3D imaging to precisely guide the injection of anesthesia, aiming to improve the success rate on the first try and reduce pain and tissue damage.

To participate in this trial, individuals must be patients at Boston University’s dental school and need non-surgical endodontic therapy (a common dental procedure) on specific teeth in the lower jaw. They should be generally healthy and have certain dental conditions that allow for treatment. Participants can expect to receive anesthesia through this new guided method, and the trial will help researchers learn about its safety and effectiveness. It's important to note that not everyone can join; for example, individuals with allergies to specific medications or those who are pregnant won't be eligible.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient of Henry M. Goldman School of Dentistry (GSDM)
  • Medical History indicating American Society of Anesthesiology (ASA)1
  • Need Non-surgical Endodontic Therapy on Mandibular Molar or Premolar
  • Asymptomatic pulpal diagnosis (normal, necrotic, asymptomatic irreversible pulpitis, retreatment with no symptoms)
  • The quadrant to be treated must have at least 3 vital teeth.
  • Going to receive a CBCT required for clinical purposes
  • Must be willing to receive guided IANB
  • Exclusion Criteria:
  • Allergy to lidocaine or articaine
  • Resin allergy
  • Normal teeth unresponsive to thermal testing (ie calcified chamber)
  • Prior jaw surgery
  • Currently pregnant

About Boston University

Boston University, a leading research institution located in Boston, Massachusetts, is dedicated to advancing health sciences through innovative clinical trials and research initiatives. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive network of experts and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes and addressing pressing health challenges. Boston University is committed to ethical research practices, patient safety, and the dissemination of findings to foster greater understanding and advancements in medical care.

Locations

Patients applied

0 patients applied

Trial Officials

Tum-Yi Hsu, DMD DScD

Principal Investigator

BU Goldman School of Dental Medicine, Endodontics

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported